» Articles » PMID: 7760804

E2F-5, a New E2F Family Member That Interacts with P130 in Vivo

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1995 Jun 1
PMID 7760804
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

E2F DNA binding sites are found in a number of genes whose expression is tightly regulated during the cell cycle. The activity of E2F transcription factors is regulated by association with specific repressor molecules that can bind and inhibit the E2F transactivation domain. For E2F-1, E2F-2, and E2F-3, the repressor is the product of the retinoblastoma gene, pRb. E2f-4 interacts with pRb-related p107 and not with pRb itself. Recently, a cDNA encoding a third member of the retinoblastoma gene family, p130, was isolated. p130 also interacts with E2F DNA binding activity, primarily in the G0 phase of the cell cycle. We report here the cloning of a fifth member of the E2F gene family. The human E2F-5 cDNA encodes a 346-amino-acid protein with a predicted molecular mass of 38 kDa. E2F-5 is more closely related to E2F-4 (78% similarity) than to E2F-1 (57% similarity). E2F-5 resembles the other E2Fs in that it binds to a consensus E2F site in a cooperative fashion with DP-1. By using a specific E2F-5 antiserum, we found that under physiological conditions, E2F-5 interacts preferentially with p130.

Citing Articles

Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.

Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R Biology (Basel). 2023; 12(12).

PMID: 38132337 PMC: 10740672. DOI: 10.3390/biology12121511.


Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.

Cornwell J, Crncec A, Afifi M, Tang K, Amin R, Cappell S Nature. 2023; 619(7969):363-370.

PMID: 37407814 PMC: 10338338. DOI: 10.1038/s41586-023-06274-3.


A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.

Li H, Dong L, Jin M, Li Q, Wang X, Jia M Molecules. 2023; 28(3).

PMID: 36770809 PMC: 9920120. DOI: 10.3390/molecules28031141.


Phosphoprotein-based biomarkers as predictors for cancer therapy.

Carter A, Tan C, Pozo K, Telange R, Molinaro R, Guo A Proc Natl Acad Sci U S A. 2020; 117(31):18401-18411.

PMID: 32690709 PMC: 7414192. DOI: 10.1073/pnas.2010103117.


HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy.

Thomas R, Oleinik N, Selvam S, Vaena S, Dany M, Nganga R EMBO Mol Med. 2017; 9(8):1030-1051.

PMID: 28606997 PMC: 5538428. DOI: 10.15252/emmm.201607088.


References
1.
Helin K, Lees J, Vidal M, Dyson N, Harlow E, Fattaey A . A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 1992; 70(2):337-50. DOI: 10.1016/0092-8674(92)90107-n. View

2.
Beijersbergen R, Kerkhoven R, Zhu L, Carlee L, Voorhoeve P, Bernards R . E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 1994; 8(22):2680-90. DOI: 10.1101/gad.8.22.2680. View

3.
Lees E, Faha B, Dulic V, Reed S, Harlow E . Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 1992; 6(10):1874-85. DOI: 10.1101/gad.6.10.1874. View

4.
Shan B, Zhu X, Chen P, Durfee T, Yang Y, Sharp D . Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol. 1992; 12(12):5620-31. PMC: 360501. DOI: 10.1128/mcb.12.12.5620-5631.1992. View

5.
Slansky J, Li Y, Kaelin W, Farnham P . A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol. 1993; 13(3):1610-8. PMC: 359473. DOI: 10.1128/mcb.13.3.1610-1618.1993. View